Affiliation:
1. Department of Gynecology and Obstetrics, Kafkas University, Faculty of Medicine, Kars, Turkey
2. Department of Pediatrics, Kafkas University, Faculty of Medicine, Kars, Turkey
Abstract
Objectives: The rates of vaccination with human papillomavirus (HPV) vaccine, which can prevent many cancers, rank the last place when compared to other childhood vaccination rates. The purpose of the present study was to evaluate the knowledge levels of mothers living in our region about HPV vaccine and their perspectives regarding having the vaccine.
Methods: The study was conducted between 15 July and 15 August 2022 in the Department of Obstetrics and Gynecology, Faculty of Medicine, Kafkas University with the mothers of 377 girls. The SPSS 21 program was used and p < 0.05 was accepted as significant.
Results: No statistically significant differences were detected between the desire of the mother to have her child vaccinated against HPV and the age of her child (p = 0.740), income level of the household (p = 0.590) and the working status of the mother (p = 0.419). There were statistically significant differences between the desire of the mother to have her daughter vaccinated with HPV, the place where the mother lived (p = 0.001), age of the mother (p = 0.037), family type (p = 0.001), number of people living at home (p = 0.027), education year of the mother (p = 0.004), father’s approval for vaccination (p = 0.001), and mother’s hearing about the Smear Test (p = 0.001).
Conclusions: Even if the HPV vaccine is given free of charge, there is resistance in mothers to the vaccine. It is necessary to inform mothers about HPV vaccination for their daughters and to make the vaccination more widespread.
Publisher
The European Research Journal
Reference30 articles.
1. 1. STD Facts - HPV and Men. Avaible at: http://www.cdc.gov/std/hpv/stdfact-hpv-and-men.htm. Accessed date: September 24, 2022.
2. 2. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervico vaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 2002;186:737-42.
3. 3. Koutsky L. Epidemiology of genital human papilloma virus infection. Am J Med 1997;102(5A):3-8.
4. 4. Mabeya H, Odunga J, Broeck DV. Mothers of adolescent girls and human papilloma virus (HPV) vaccination in Western Kenya. Pan Afr Med J 2021;38:126.
5. 5. Caballero-Pérez P, Tuells J, Rementería J, Nolasco A, Navarro-López V, Arístegui J. [Acceptability of the HPV vaccine among Spanish university students in the pre-vaccine era: a cross-sectional study]. Rev Esp Quimioter 2015;28:21-8. [Article in Spanish]